ArticleNature communications2026
Structural basis and regulation of GSDME pore formation.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- The gasdermin family: from pyroptosis mechanisms to therapeutic targets.Signal transduction and targeted therapy · 2026Review
- Structural basis of GSDME pore formation and its regulation by S-palmitoylation.Proceedings of the National Academy of Sciences of the United States of America · 2026Article
- Theme and variations: activation and regulation of gasdermin-mediated inflammation.Biochemical Society transactions · 2026Review
- Beyond apoptosis: harnessing natural products to target alternative regulated cell death for overcoming multidrug resistance in cancer.Frontiers in oncology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Gasdermins (GSDMs) are pore-forming proteins that mediate pyroptosis and contribute to inflammatory and cancer-related processes. Although GSDME shares structural similarity with other gasdermins, its activation and pore assembly mechanisms remain incompletely defined. Here we determine high-resolution cryo-electron microscopy structures of 27- and 28-fold human GSDME pores at 3.64 Å and 3.58 Å resolution. The structures reveal conserved structural architecture together with distinct features, including an extended transmembrane β-barrel and a comparatively compact membrane-engagement geometry. Structure-guided mutagenesis identifies lipid-binding and oligomerization interfaces required for pore formation. We further demonstrate that caspase-3 activates GSDME through direct recognition of a DMPD tetrapeptide motif within the interdomain linker, independently of the GSDME C-terminal domain. Following proteolytic activation, S-palmitoylation of GSDME N-terminal domain enhances pore-forming efficiency, with Cys180 serving as the primary functional site. Together, these findings establish a coordinated structural and regulatory framework in which proteolytic licensing and lipid modification sequentially control GSDME pore formation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.